0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover229.42%IV-12.32%PremiumNov 8, 2024Expiry Date2.46Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7593Delta0.0701Gamma6.29Leverage Ratio-0.2132Theta0.0011Rho4.77Eff Leverage0.0060Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet